Berenberg Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy

September 15, 2026 1:17 AM

Berenberg analyst Kerry Holford upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Hold to Buy with a price target of GBP22.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found